Equity Overview
Price & Market Data
Price: $2.99
Daily Change: -$0.01 / 0.33%
Range: $2.91 - $3.07
Market Cap: $11,107,185
Volume: 10,795
Performance Metrics
1 Week: 8.52%
1 Month: -10.78%
3 Months: -35.72%
6 Months: -84.18%
1 Year: -89.00%
YTD: -65.19%
Company Details
Employees: 28
Sector: Health technology
Industry: Pharmaceuticals: major
Country: Israel
Details
BioLineRx Ltd., a commercial stage biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company's pipeline includes APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the treatment of pancreatic cancer, as well as completed Phase 3 clinical trial for the treatment of multiple myeloma. It also develops BL-5010, a pen-like applicator containing an acidic aqueous solution for the non-surgical removal of skin lesions. BioLineRx Ltd. was incorporated in 2003 and is headquartered in Hevel Modi'in, Israel.